Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump)
Not yet recruitingOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
February 28, 2022
Primary Completion Date
February 28, 2022
Study Completion Date
March 31, 2028
Conditions
Parkinson's Disease
Trial Locations (1)
67098
Mathieu ANHEIM, Strasbourg
All Listed Sponsors
lead
University Hospital, Strasbourg, France
OTHER
NCT05072015 - Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump) | Biotech Hunter | Biotech Hunter